James Killick

[email protected]

James Killick led the firm’s global pharmaceuticals and healthcare practice from 2010 to 2014. He regularly advises leading pharma­ceutical multinationals and the major US and EU industry pharmaceutical associations on EU and national law and policy affecting the pharmaceuticals sector.His pharmaceutical practice covers competition law, including licensing and distribution issues, regulatory matters, intellectual property, data protection and national implementation of EU measures, notably on pricing and reimbursement.He has been involved in pleading a number of leading cases in the European Courts, including Microsoft v. Commission (compulsory licensing; treatment of trade secrets), Hanner (Swedish retail monopoly on pharmaceuticals), Pfizer v. Council (precautionary principle), IMS Health (compulsory licensing), and Servier v. Commission (banning of pharmaceuticals).He was actively involved in the European Commission’s pharma­ceutical sector inquiry, representing a major global company, and has spoken extensively on this topic.

Content from this author

Get unlimited access to all Global Competition Review content